Appraisal of anti-inflammatory and immunomodulatory potential of ramipril against Freund's adjuvant-provoked arthritic rat model

Inflammopharmacology. 2023 Dec;31(6):3115-3125. doi: 10.1007/s10787-023-01306-w. Epub 2023 Aug 6.

Abstract

Because of evident role of renin-angiotensin system in the etiology of rheumatoid arthritis, the current study's objective was to assess the anti-arthritic efficacy of ramipril through CFA-instigated arthritic model. The drug has been shown to have anti-inflammatory potential. CFA-instigated arthritic model assessed the anti-arthritic efficacy of ramipril by estimating different parameters, including paw volume, arthritic index scoring, haematological and biochemical attributes, histological and radiographic analyses, and various cytokines level. Ramipril significantly (p < 0.001) reduced paw volume and the arthritic index especially at the dose of 4mg/kg. The biochemical and haematological changes were likewise restored to normal by ramipril administration with an increase in anti-inflammatory cytokines while reducing pro-inflammatory cytokines level. Ramipril's ability to prevent arthritis by preserving the normal architecture of arthritis-induced joints is further supported by radiographic and histological investigation. The study's findings demonstrated ramipril's considerable anti-arthritic activity. To identify the precise mechanism of action, however, thorough mechanistic studies are still needed.

Keywords: Anti-inflammatory cytokines; Arthritis; CFA; Pro-inflammatory cytokines; Ramipril.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Arthritis, Experimental* / chemically induced
  • Arthritis, Experimental* / drug therapy
  • Arthritis, Experimental* / pathology
  • Cytokines
  • Freund's Adjuvant
  • Plant Extracts / pharmacology
  • Ramipril* / adverse effects
  • Rats

Substances

  • Freund's Adjuvant
  • Ramipril
  • Plant Extracts
  • Anti-Inflammatory Agents
  • Cytokines